KEYHOLE THERAPEUTICS
Keyhole Therapeutics is a discovery stage drug company specializing in immunotherapies for cancer and autoimmune diseases. Keyhole's first program, a small molecule inhibitor of exosome release being investigated for promotion of immune-driven tumor destruction in cancer patients resistant to current immune checkpoint inhibitors, is at the hit-to-lead stage. Future programs will include additional inhibitors of exosome release, and novel exosome-related therapeutic opportunities for cellular cancer vaccines and for targeted suppression of autoreactive T cells. Keyhole Therapeutics is seeking bold, accomplished, and innovative scientists to join them in pioneering the next wave of immunotherapeutics.
KEYHOLE THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2019-01-01
Address:
San Francisco, California, United States
Country:
United States
Status:
Active
Total Funding:
0
Similar Organizations
Georgiamune
Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.
NovelMed Therapeutics
NovelMed Therapeutics is a biotechnology company developing novel therapies for orphan and non-orphan diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Founder
Investors List
MBC BioLabs
MBC BioLabs investment in Pre Seed Round - Keyhole Therapeutics
More informations about "Keyhole Therapeutics"
Keyhole Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Keyhole Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Keyhole Therapeutics - Funding, Financials, Valuation & Investors
Keyhole Therapeutics is a discovery stage drug company specializing in immunotherapies for cancer and autoimmune diseases. Search Crunchbase. Start Free Trial . ... How much funding …See details»
Keyhole Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Keyhole Therapeutics Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
KEYHOLE THERAPEUTICS INC. in San Francisco, CA | Company Info …
Aug 21, 2024 KEYHOLE THERAPEUTICS INC. is a California Stock Corporation - Out Of State - Stock filed on August 6, 2019. The company's filing status is listed as Active and its File …See details»
Keyhole Therapeutics Inc. in San Francisco CA - Company Profile
Keyhole Therapeutics Inc. Overview. Keyhole Therapeutics Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Tuesday, August 6, 2019 and …See details»
Keyhole Therapeutics Inc. · 215 10th Ave, San Francisco
KEYHOLE THERAPEUTICS INC. is an entity in San Francisco, California registered with the System for Award Management (SAM) of U.S. General Services Administration (GSA). The …See details»
KEYHOLE THERAPEUTICS LLC :: Indiana (US) - OpenCorporates
Free and open company data on Indiana (US) company KEYHOLE THERAPEUTICS LLC (company number 201804051250283) Changes to our website — to find out why access to …See details»
Keyhole Therapeutics Inc. - CAGE.report
KEYHOLE THERAPEUTICS INC. D-U-N-S: 117233526: S.A.M. Registration: 8ESB7 [117233526] KEYHOLE THERAPEUTICS INC. Company Details. Identification, Location & Contacts ...See details»
Keyhole Therapeutics - Crunchbase
Keyhole Therapeutics is a discovery stage drug company specializing in immunotherapies for cancer and autoimmune diseases. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
KEYHOLE THERAPEUTICS INC. - CAGE.report
Keyhole Therapeutics Inc. has a registered CAGE Code for doing business with the United States government. Cage Code 8ESB7 was last updated on 2020-08-21 with the following company …See details»
KEYHOLE THERAPEUTICS INC. :: California (US) - OpenCorporates
Aug 6, 2019 Free and open company data on California (US) company KEYHOLE THERAPEUTICS INC. (company number 4305347), 215 10TH AVENUE SAN FRANCISCO …See details»
Keyhole Therapeutics Inc. Company Profile -Sales, Contacts, …
Keyhole Therapeutics Inc. is in the Business Activities At Non-Commercial Site industry within the Business Services sector and has been in business for approximately (5) years. The Most …See details»
KEYHOLE THERAPEUTICS INC San Francisco CA, 94118 - Cortera
Free Business profile for KEYHOLE THERAPEUTICS INC at 215 10th Ave, San Francisco, CA, 94118-2212, US. KEYHOLE THERAPEUTICS INC specializes in: Commercial Physical and …See details»
Biography of John Hunter - The Official Board
John was Chief Executive and Scientific Officer at Keyhole Therapeutics, and Chief Scientific Officer at Compugen. John Hunter is currently Chief Scientific Officer at Fibrogen - View - …See details»
Astellas and MBC BioLabs Announce Future Innovator Prize to …
Sep 21, 2021 The 2020 Astellas Golden Ticket winners were Keyhole Therapeutics, Inc. and Jupiter Therapeutics, Inc., chosen for the potential of their innovations to deliver therapeutic …See details»
FibroGen Appoints John Hunter, Ph.D. as Chief Scientific Officer
Jul 12, 2021 Dr. Hunter most recently served as Chief Executive & Scientific Officer of Keyhole Therapeutics Inc, a private immuno-oncology company. Prior to Keyhole, John spent 8 years …See details»
Astellas Golden Ticket Winners 2020 - MBC BioLabs
Dec 14, 2020 Keyhole Therapeutics is a discovery stage drug company translating groundbreaking work by its ... AVM is the wholly-owned venture capital organization within …See details»
After getting ditched by Big Pharma veteran, FibroGen hopes it …
Jul 19, 2021 He most recently served as CEO and CSO of private immuno-oncology biotech Keyhole Therapeutics. “John’s expertise and experience make him the ideal person to lead …See details»
MBC BioLabs - Investments, Portfolio & Company Exits - Crunchbase
How many investments has this organization made over time? Show . Which industries has this organization most actively invested in? Show . Announced Date . Organization Name ... Pre …See details»